BRPI0712101B8 - ácido beta-fenil-alfa-hidróxi propanóico substituído, método de síntese e uso do mesmo - Google Patents

ácido beta-fenil-alfa-hidróxi propanóico substituído, método de síntese e uso do mesmo

Info

Publication number
BRPI0712101B8
BRPI0712101B8 BRPI0712101A BRPI0712101A BRPI0712101B8 BR PI0712101 B8 BRPI0712101 B8 BR PI0712101B8 BR PI0712101 A BRPI0712101 A BR PI0712101A BR PI0712101 A BRPI0712101 A BR PI0712101A BR PI0712101 B8 BRPI0712101 B8 BR PI0712101B8
Authority
BR
Brazil
Prior art keywords
alpha
phenyl
synthesis
compound
formula
Prior art date
Application number
BRPI0712101A
Other languages
English (en)
Inventor
Zhang Qunzheng
Wang Shixiang
Zheng Xiaohui
Zhao Xinfeng
Original Assignee
Univ Northwest
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Northwest filed Critical Univ Northwest
Publication of BRPI0712101A2 publication Critical patent/BRPI0712101A2/pt
Publication of BRPI0712101B1 publication Critical patent/BRPI0712101B1/pt
Publication of BRPI0712101B8 publication Critical patent/BRPI0712101B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/48—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/65—Halogen-containing esters of unsaturated acids
    • C07C69/653—Acrylic acid esters; Methacrylic acid esters; Haloacrylic acid esters; Halomethacrylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

ácido beta-fenil-alfa-hidróxi propanóico substituído, método de síntese e uso do mesmo. a presente invenção refere-se a um composto da fórmula (l), (i) onde r1 r2 e r3 são cada um independentemente selecionados do grupo que consiste em h, oh, f, cl, br, metóxi e etóxi; ou alternativamente, r1 e r2 juntos formam -och2o, r3 é selecionado do grupo que consiste em h, oh, metóxi, etóxi e halogênios; r4 é oh ou acilóxi; r5 é selecionado de cicloalcóxila, amino e amino substituído, e quando r5 é selecionado de amino, pelo menos um de r1, r2 e r3 não é h. a presente invenção refere-se ainda a um processo para sintetizar um composto da fórmula (l), e ao uso do composto da fórmula (l) na produção de um medicamento para a prevenção ou o tratamento de doenças cardiovasculares ou cerebrovasculares.
BRPI0712101A 2006-05-15 2007-05-14 ácido beta-fenil-alfa-hidróxi propanóico substituído, método de síntese e uso do mesmo BRPI0712101B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB2006100427873A CN100415709C (zh) 2006-05-15 2006-05-15 β-(3,4-二羟基苯基)-α-羟基丙酸冰片酯、其合成方法和用途
CN200610042787.3 2006-05-15
PCT/CN2007/001550 WO2007131446A1 (fr) 2006-05-15 2007-05-14 Acide bêta-phényl-alpha-hydroxy propanoïque substitué, procédé de synthèse et son utilisation

Publications (3)

Publication Number Publication Date
BRPI0712101A2 BRPI0712101A2 (pt) 2012-01-17
BRPI0712101B1 BRPI0712101B1 (pt) 2020-08-11
BRPI0712101B8 true BRPI0712101B8 (pt) 2021-05-25

Family

ID=37442796

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0712101A BRPI0712101B8 (pt) 2006-05-15 2007-05-14 ácido beta-fenil-alfa-hidróxi propanóico substituído, método de síntese e uso do mesmo

Country Status (20)

Country Link
US (1) US8017786B2 (pt)
EP (2) EP2514739B1 (pt)
JP (1) JP5094845B2 (pt)
KR (1) KR101059639B1 (pt)
CN (1) CN100415709C (pt)
AU (1) AU2007250364B8 (pt)
BR (1) BRPI0712101B8 (pt)
CA (1) CA2652299C (pt)
CY (2) CY1113676T1 (pt)
DK (2) DK2514739T3 (pt)
ES (1) ES2618677T3 (pt)
HU (1) HUE032505T2 (pt)
IL (1) IL195313A (pt)
MY (1) MY148134A (pt)
NZ (1) NZ572958A (pt)
PL (2) PL2514739T3 (pt)
PT (1) PT2514739T (pt)
RU (1) RU2421443C2 (pt)
SI (2) SI2019090T1 (pt)
WO (1) WO2007131446A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100415709C (zh) 2006-05-15 2008-09-03 西北大学 β-(3,4-二羟基苯基)-α-羟基丙酸冰片酯、其合成方法和用途
CN101607897B (zh) * 2008-06-18 2012-10-24 复旦大学 (z)-2-乙酰氧基-3-(3,4-二羟基苯基)丙烯酸及其合成方法和用途
MX355697B (es) 2010-04-12 2018-04-27 Supernus Pharmaceuticals Inc Métodos para producir sales de viloxazina y polimorfos novedosos de las mismas.
CN102030648B (zh) * 2010-12-07 2013-04-03 西北大学 3-(3,4-二羟基苯基)-2-羟基丙酸酯的不对称合成方法
CN102432468B (zh) * 2011-11-21 2014-03-26 中国人民解放军第四军医大学 丹参素冰片酯的不对称合成方法
WO2014091465A2 (en) * 2012-12-16 2014-06-19 Mahesh Kandula Compositions and methods for the treatment of metabolic syndrome and lipid disorders
CN103232347B (zh) * 2013-04-12 2015-09-16 合肥工业大学 一种cns药物的脑靶向前药及其制备方法以及冰片在cns药物脑靶向前药中的用途
CN103570547B (zh) * 2013-10-09 2016-04-20 西安石油大学 一种丹参素异丙酯的工业化合成方法
CN103570546B (zh) * 2013-10-09 2016-05-18 西安石油大学 一种丹参素冰片酯的工业化合成方法
CN105693817B (zh) 2014-11-27 2020-06-05 西北大学 一类三肽化合物及其制备方法与应用
CN106496897A (zh) * 2016-10-14 2017-03-15 无锡三帝特种高分子材料有限公司 一种聚酯镀铝膜
CN107619376A (zh) * 2017-11-09 2018-01-23 宁波职业技术学院 一种缬氨酸冰片酯及其制备方法和应用
CN109928959B (zh) * 2017-12-18 2020-11-06 中国科学院上海营养与健康研究所 抗心肌肥厚的药物、制备方法和用途
CN108047048B (zh) 2017-12-30 2021-01-12 苏州沪云肿瘤研究中心股份有限公司 一种苯丙酸酯类化合物及其制备方法和应用
CN109608356B (zh) * 2018-12-14 2021-11-05 南京医科大学 一类丙二酸单酯酰化的氨基酸(+)2-崁醇酯的衍生物及其应用
JP6768868B2 (ja) * 2019-03-29 2020-10-14 健裕生技股▲分▼有限公司 心筋再生を促進させるための化合物、その調製方法及びこれらの使用
JP2020164528A (ja) * 2020-04-28 2020-10-08 健裕生技股▲分▼有限公司 心筋再生を促進させるための化合物、その調製方法、医薬組成物及びこれらの使用
CN114394901A (zh) * 2021-12-30 2022-04-26 广东医科大学附属第二医院 一种丹参素特戊酸甲酯衍生物及其制备方法
US11891353B1 (en) 2023-08-28 2024-02-06 King Faisal University 3,3′-(hydrazine-1,2-diyl)bis(1-(naphthalen-2-yloxy)propan-2-ol) as an ecofriendly insecticidal agent against Spodoptera littoralis (boisd.)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60255774A (ja) * 1984-06-01 1985-12-17 Dai Ichi Seiyaku Co Ltd テトラヒドロナフタレン誘導体
RU2092169C1 (ru) 1992-08-20 1997-10-10 Раиса Павловна Свистунова Местное противовоспалительное средство "сальвинол"
JP3050733B2 (ja) * 1992-10-16 2000-06-12 中外製薬株式会社 ４−アルコキシ−２，６−ジ−ｔ−ブチルフェノール誘導体
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
WO1997015546A1 (fr) * 1995-10-26 1997-05-01 Nippon Shinyaku Co., Ltd. Derives d'acide carboxylique et compositions pharmaceutiques
CN1161140C (zh) * 2001-11-09 2004-08-11 天津天士力制药股份有限公司 一种预防和治疗冠心病心绞痛的药物及其制备方法和其它用途
US20040248849A1 (en) * 2001-06-28 2004-12-09 Potlapally Rajender Kumar 3-Aryl-A-oxy substituted propanoic acids and a process for their preparation
FR2842523A1 (fr) * 2002-07-17 2004-01-23 Sanofi Synthelabo Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
CN100441563C (zh) * 2004-06-03 2008-12-10 西安交通大学 β-（3，4-二羟基苯基）-α-羟基丙酸异丙酯及其合成方法
CN100415709C (zh) 2006-05-15 2008-09-03 西北大学 β-(3,4-二羟基苯基)-α-羟基丙酸冰片酯、其合成方法和用途

Also Published As

Publication number Publication date
MY148134A (en) 2013-02-28
NZ572958A (en) 2011-11-25
IL195313A (en) 2013-12-31
EP2514739B1 (en) 2016-12-21
KR101059639B1 (ko) 2011-08-25
CA2652299A1 (en) 2007-11-22
AU2007250364B8 (en) 2012-01-19
CN1868998A (zh) 2006-11-29
PT2514739T (pt) 2017-03-09
PL2514739T3 (pl) 2017-09-29
EP2514739A1 (en) 2012-10-24
CY1113676T1 (el) 2016-06-22
AU2007250364B2 (en) 2011-05-26
RU2008145090A (ru) 2010-06-20
RU2421443C2 (ru) 2011-06-20
BRPI0712101A2 (pt) 2012-01-17
ES2618677T3 (es) 2017-06-21
KR20090013231A (ko) 2009-02-04
CA2652299C (en) 2011-12-20
JP2009537462A (ja) 2009-10-29
WO2007131446A1 (fr) 2007-11-22
PL2019090T3 (pl) 2013-02-28
CN100415709C (zh) 2008-09-03
EP2019090A1 (en) 2009-01-28
IL195313A0 (en) 2009-08-03
AU2007250364A1 (en) 2007-11-22
EP2019090B1 (en) 2012-11-14
US8017786B2 (en) 2011-09-13
SI2019090T1 (sl) 2013-02-28
DK2019090T3 (da) 2013-01-21
EP2019090A4 (en) 2010-01-27
HUE032505T2 (en) 2017-09-28
SI2514739T1 (sl) 2017-04-26
BRPI0712101B1 (pt) 2020-08-11
JP5094845B2 (ja) 2012-12-12
DK2514739T3 (en) 2017-04-03
US20090131677A1 (en) 2009-05-21
CY1118722T1 (el) 2017-07-12

Similar Documents

Publication Publication Date Title
BRPI0712101B8 (pt) ácido beta-fenil-alfa-hidróxi propanóico substituído, método de síntese e uso do mesmo
BRPI0417543A (pt) quinolinas úteis no tratamento de doença cardiovascular
BRPI0410238A (pt) compostos orgánicos
BRPI0507034A (pt) compostos orgánicos
BRPI0813284A8 (pt) Processo para a preparação de um composto da fórmula (i) e composto
BRPI0615691A8 (pt) Método para a preparação de 6-((3s,4r)-4-(4-amino-5-cloro-2-metoxibenzamido)-3-metoxipiperidin-1-il) hexanoato de (r)-quinuclidin-3-ila ou sal do mesmo
BRPI0413934A (pt) compostos orgánicos
EA200900023A1 (ru) Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли
BRPI0512060B8 (pt) compostos orgânicos, composições farmacêuticas compreendendo os mesmos, bem como uso e processo de preparação dos referidos compostos
MA29539B1 (fr) Procedes de production de derives phenoliques 4-biphenylylazetidin -2-one
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
DE602007007666D1 (de) Verfahren zur herstellung von nebivolol
BRPI0513278A (pt) uso de um composto, composto, composição farmacêutica, processo para produzir um composto, e, método para causar a morte celular através de terapia de ativação por fóton
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
ATE488509T1 (de) Verfahren zur herstellung von substituierten tetrazolen aus aminotetrazolen
DE602004031907D1 (de) Verfahren zur Herstellung von Nanopartikeln durch grössenspezifische Photoätzung
ATE543494T1 (de) Griseofulvin-analoga zur behandlung von krebs durch hemmung von zentrosomaler clusterbildung
BRPI0411294A (pt) derivados de amino-propanol
BRPI0900983A2 (pt) compostos de diometina, processo para sua preparação e composições farmacêuticas contendo os mesmos
BRPI0417741A (pt) aldiminoalquilsilanos
CR9182A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene
BRPI0411738A (pt) compostos orgánicos
ES2333026T3 (es) Derivados de ciclohexil-1,4-diamina sustituidos.
BRPI0413709A (pt) compostos para o tratamento de distúrbios neurodegenerativos
DE60312029D1 (de) Verfahren zur herstellung c-7 substituierter 5-androstene

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/08/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/05/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF